chr22-50571473-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000312108.12(CPT1B):āc.1642T>Gā(p.Cys548Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000217 in 1,613,812 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000312108.12 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CPT1B | NM_152246.3 | c.1642T>G | p.Cys548Gly | missense_variant | 14/20 | ENST00000312108.12 | NP_689452.1 | |
CHKB-CPT1B | NR_027928.2 | n.3212T>G | non_coding_transcript_exon_variant | 24/30 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPT1B | ENST00000312108.12 | c.1642T>G | p.Cys548Gly | missense_variant | 14/20 | 1 | NM_152246.3 | ENSP00000312189 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152252Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000683 AC: 17AN: 248898Hom.: 1 AF XY: 0.0000594 AC XY: 8AN XY: 134766
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461442Hom.: 0 Cov.: 32 AF XY: 0.0000234 AC XY: 17AN XY: 727010
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152370Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74514
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2023 | The c.1642T>G (p.C548G) alteration is located in exon 14 (coding exon 13) of the CPT1B gene. This alteration results from a T to G substitution at nucleotide position 1642, causing the cysteine (C) at amino acid position 548 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at